📦 NDC / package directory — not a drug information page
Tafasitamab NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Tafasitamab products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
3
Package NDCs
3
Products
3
Active listings
0
Discontinued
2
Labelers
3
Strengths
3
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| tafasitamab 40 mg/40mg SOLUTION | 12714-0212-40 | — | On market | View → |
| Tafasitamab 200 mg/200mg POWDER | 12714-0219-40 | — | On market | View → |
| Tafasitamab 42 mg/mL LIQUID | 67643-0029-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.